← Back to front page
Asia · Financial press · SCMP Business

Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback

Published by SCMP Business · Hong Kong 18 min ago
Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback
SCMP Business

Detailed summary

Shares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US Food and Drug Administration (FDA) rejected its cancer drug application, raising…

Read the full article on SCMP Business Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.scmp.com)

Also worth reading